Primary Site >> Pancreatic Cancer

Gene >> NEUROD1

  • 1978
  • 1979
  • 1983
  • 1996
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2016
  • 2018
Ref: [The significance of beta2-microglobulin and carcinoembryonic antigen in the diagnosis of the carcinoma of the pancreas (author's transl)].
PMID: 76694
Ref: [beta2-Microglobulin in cancer patients (author's transl)].
PMID: 83577
Ref: Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
PMID: 371789
Ref: The use and mechanism of urinary clearance of cathodic trypsin-like immunoreactivity to creatinine clearance ratio in the diagnosis of pancreatic cancer.
PMID: 6347435
Ref: Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
PMID: 8666926
Ref: Differentiation of islet cells in long-term culture.
PMID: 10824687
Ref: Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
PMID: 10933198
Ref: BETA2 and pancreatic islet development.
PMID: 11237215
Ref: Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas.
PMID: 11238189
Ref: Retinoic acid receptor beta2 inhibition of metastasis in mouse mammary gland xenografts.
PMID: 12000222
Ref: Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
PMID: 12527944
Ref: Regulation of the human secretin gene is controlled by the combined effects of CpG methylation, Sp1/Sp3 ratio, and the E-box element.
PMID: 15118068
Ref: Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers.
PMID: 15985535
Ref: Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
PMID: 16855371
Ref: Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
PMID: 19106745
Ref: Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol.
PMID: 19724861
Ref: beta2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFkappaB and AP-1.
PMID: 20424515
Ref: miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
PMID: 21329664
Ref: beta2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFkappaB pathway.
PMID: 22118662
Ref: Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via beta-adrenergic receptor-dependent activation of P38/MAPK pathway.
PMID: 22020907
Ref: [Expression and significance of neurogenic differentiation protein in pancreatic carcinoma].
PMID: 22455846
Ref: Association of single nucleotide polymorphisms of beta2-adrenergic receptor gene with clinicopathological features of pancreatic carcinoma.
PMID: 22817959
Ref: beta2-AR-HIF-1alpha: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis.
PMID: 23745588
Ref: Effect of NeuroD gene silencing on the migration and invasion of human pancreatic cancer cells PANC-1.
PMID: 24464628
Ref: beta2-adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1alpha.
PMID: 26497365
Ref: Genomic analyses identify molecular subtypes of pancreatic cancer.
PMID: 26909576
Ref: beta2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.
PMID: 29249692
Ref: Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFbeta, in Advanced Solid Tumors.
PMID: 29298798
Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review).
PMID: 29786110